5 Key Takeaways
-
1
Johnson & Johnson will present new data on the TECNIS PureSee EDOF IOL at the 2026 ASCRS Annual Meeting in Washington, DC.
-
2
The TECNIS PureSee lens is designed to extend vision range beyond standard monofocal lenses while maintaining contrast sensitivity.
-
3
A US clinical trial showed the lens provides strong distance vision and improved intermediate performance compared to a monofocal control.
-
4
Post-market studies indicated high patient satisfaction, with 96% achieving distance spectacle independence and low visual disturbance rates.
-
5
Johnson & Johnson will also present additional data on the TECNIS platform, highlighting high spectacle independence and low dysphotopsia rates.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.